News Industry News Micell Technologies Announces First Patient Enrolled in Registration Trial of MiStent SES in China July 22, 2015
News Industry News DalCor Pharma licenses a late-stage investigational cardiovascular drug following major discovery by Montreal Heart Institute (MHI) scientists June 08, 2015